XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.4
Interim Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Dec. 31, 2022
Sep. 30, 2022
Current    
Cash and cash equivalents $ 143,621,848 $ 149,157,861
Incentive and tax receivables 4,094,431 3,192,580
Prepaid expenses and other current assets 655,643 354,162
Total Assets 148,371,922 152,704,603
Current Liabilities    
Accounts payable 5,288,261 3,824,777
Accrued liabilities - Note 4 7,042,822 5,944,953
Deferred grant income - Note 3 916,763 443,831
Total Liabilities 13,247,846 10,213,561
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share78,032,135 common shares (September 30, 2022 - 77,942,815) 78,033 77,944
Additional paid-in capital 393,581,544 387,976,881
Accumulated deficit (258,535,501) (245,563,783)
Total Stockholders' Equity 135,124,076 142,491,042
Total Liabilities and Stockholders' Equity $ 148,371,922 $ 152,704,603